Skip to main content
. 2019 Sep 18;10:998. doi: 10.3389/fneur.2019.00998

Figure 2.

Figure 2

Percentage improvement of UPDRS III as H&Y factor in the group. Active vs. Placebo. *p ≤ 0.05.